No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Renhe Pharmacy Co., Ltd. is a pharmaceutical enterprise engaged in the manufacturing and distribution of a wide array of products. Its diverse portfolio includes both traditional Chinese and modern Western medicines, their essential raw materials, and various health and wellness items. These offerings are presented in numerous forms, such as oral solid preparations (e.g., tablets, capsules), liquid medications, large and small volume injectable solutions, topical treatments like lotions, liniments, and ointments, as well as suppositories and other health-related product formats. The company, which was established in 1996, maintains its corporate headquarters in Nanchang, China.
www.renheyaoye.comNo one on the platform currently holds 000650.SZ.
No tracked institution reports a position in 000650.SZ as of their last filing.
No one on the platform has traded 000650.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 13.9% | 18.9% | 22.3% | — | — | — |
| Rev. Growth % | -13.2% | -3.7% | ||||
| Profit Margin % | 11.1% | 11.8% | 11.6% | |||
| Free Cash Flow Margin % | 22.0% | 12.2% | 12.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.8B | -33.7% | $0.29 | $0.29–$0.29 | — | 1 |
| 2027 | $4.0B | +6.0% | $0.32 | $0.32–$0.32 | — | 1 |
| 2028 | $4.3B | +6.0% | $0.35 | $0.35–$0.35 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000650.SZRenhe Pharmacy Co., Ltd. | $5.18 | -0.00% | $7.2B | — |
| 000597.SZNortheast Pharmaceutical Group Co., Ltd. | $4.66 | +0.87% | $6.6B | — |
| 000756.SZShandong Xinhua Pharmaceutical Company Limited | $12.74 | +0.08% | $6.4B | — |
| 000915.SZShandong Wit Dyne Health Co.,Ltd. | $24.13 | -0.49% | $5.7B | — |
| 000989.SZJiuzhitang Co., Ltd. |
| $8.62 |
| +0.35% |
| $7.3B |
| — |
| 300119.SZTianjin Ringpu Bio-Technology Co.,Ltd. | $17.20 | -0.06% | $8.0B | — |
| 300702.SZZhejiang Tianyu Pharmaceutical Co., Ltd. | $20.74 | +1.22% | $7.2B | — |
Source: Financial Modeling Prep · peers by sector/industry